Guardant Health
294 hedge funds and large institutions have $3.05B invested in Guardant Health in 2023 Q4 according to their latest regulatory filings, with 51 funds opening new positions, 80 increasing their positions, 117 reducing their positions, and 47 closing their positions.
28% more call options, than puts
Call options by funds: $21.9M | Put options by funds: $17.1M
1.32% more ownership
Funds ownership: 93.89% → 95.22% (+1.3%)
9% more first-time investments, than exits
New positions opened: 51 | Existing positions closed: 47
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% less funds holding
Funds holding: 295 → 294 (-1)
5% less capital invested
Capital invested by funds: $3.21B → $3.05B (-$160M)
32% less repeat investments, than reductions
Existing positions increased: 80 | Existing positions reduced: 117
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$162M |
| 2 |
Morgan Stanley
New York
|
+$72.4M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$28.2M |
| 4 |
Capital International Investors
Los Angeles,
California
|
+$28.2M |
| 5 |
Man Group
London,
United Kingdom
|
+$26.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$86M |
| 2 |
Millennium Management
New York
|
-$52.5M |
| 3 |
Jennison Associates
New York
|
-$37M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$24.3M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$19.1M |
GH Hedge Fund Activity: Q4 2023 in Review
294 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Guardant Health (GH) for Q4 2023, worth a combined $3.05B — down 5% from $3.21B a quarter earlier.
Buyers outnumbered sellers: 51 funds opened new GH positions and 47 closed out — a net gain of 4 holders — while 80 added to existing stakes and 117 trimmed.
The largest buyer was Baillie Gifford & Co, opening a new position worth an estimated $162M. The largest seller was Fidelity Investments, cutting an estimated $86M.
- 294 institutional investors held Guardant Health (GH) as of Q4 2023, down from 295 in Q3 2023.
- Funds reported $3.05B of Guardant Health stock for Q4 2023, down 5% quarter-over-quarter.
- 51 funds opened new Guardant Health positions in Q4 2023 and 47 closed out, a net change of +4 holders.
- The largest Guardant Health buyer in Q4 2023 was Baillie Gifford & Co, an estimated $162M added.
- The largest Guardant Health seller in Q4 2023 was Fidelity Investments, an estimated $86M sold.
Based on aggregated 13F filings for Q4 2023.